Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 7;103(23):e37853.
doi: 10.1097/MD.0000000000037853.

Nasopharyngeal carcinoma with leptomeningeal metastases has been treated with comprehensive treatment for long-term survival: A case report and literature review

Affiliations
Review

Nasopharyngeal carcinoma with leptomeningeal metastases has been treated with comprehensive treatment for long-term survival: A case report and literature review

Yi Yang et al. Medicine (Baltimore). .

Abstract

Rationale: Nasopharyngeal carcinoma has a high incidence in East and Southeast Asia, often with distant metastasis. However, leptomeningeal metastasis (LM) is extremely rare and usually has a poor prognosis. This paper reports the clinical treatment of a patient with meningeal metastasis of nasopharyngeal carcinoma (NPC) in order to improve the clinician's understanding of the disease. Early diagnosis of the disease can alleviate the pain of patients and prolong their survival time.

Patient concerns: We report the case of a 55-year-old female with a history of NPC with LM. Brain magnetic resonance imaging showed temporal lobe enhancement, peripheral edema, and enhancement of the adjacent meninges. Cerebrospinal fluid cytology suggests the presence of malignant tumor cells.

Diagnoses: The patient was diagnosed with LM from NPC.

Interventions: The patients were regularly given targeted therapy with nimotuzumab, immunotherapy with karyolizumab, and lumbar intrathecal methotrexate chemotherapy and supportive treatment.

Outcomes: The patient had survived for 3 years since the diagnosis of LM and was in good condition and still under active antitumor treatment.

Lessons: Leptomeningeal metastasis of NPC is a rare disease. Although there is currently no unified treatment plan, the neurological symptoms can still be controlled and the quality of life can be improved through active treatment.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
MRI of the patient’s brain at the time of confirmed leptomeningeal metastases: (A, B) meningeal enhancement, (C) left temporal lobe, and peripheral edema. MRI = magnetic resonance imaging.
Figure 2.
Figure 2.
Cytological examination of CSF in a patient with confirmed leptomeningeal metastasis (MGG staining ×1000): 2 tumor cells were visible. CSF = cerebrospinal fluid.
Figure 3.
Figure 3.
Follow-up visit in October 2023. Compared with the confirmed diagnosis, the patient’s brain MRI showed no significant deterioration. The left temporal lobe enhancement disappeared, and new right temporal lobe enhancement was found. MRI = magnetic resonance imaging.
Figure 4.
Figure 4.
Follow-up visit in October 2023. Lymphocytes, monocytes, and erythrocytes were observed in CSF cytology of the patient. CSF = cerebrospinal fluid.

Similar articles

Cited by

References

    1. Cheng H, Perez-Soler R. Leptomeningeal metastases in non-small-cell lung cancer. Lancet Oncol. 2018;19:e43–55. - PubMed
    1. Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV. Leptomeningeal metastasis from solid tumors. J Neurol Sci. 2020;411:116706. - PubMed
    1. Cheny P, Chana TC, Leq T, et al. . Nasopharyngeal carcinoma. Lancet. 2019;394:64–80. - PubMed
    1. Don K, Song YJ, Lee SK. The role of promoter methylation in Epstein–Barr virus (EBV) microRNA expression in EBV-infected B cell lines. Exp Mol Med. 2011;43:401–10. - PMC - PubMed
    1. Xiaosu G, Yue Z, Junying H, et al. . Progress in diagnosis and treatment of meningeal carcinomatosis. Chin J Nerv Ment Dis. 2017;43:53–6.

MeSH terms